Epidemiological study of health hazards among workers handling engineered nanomaterials

详细信息    查看全文

• 作者：Saou-Hsing Liou (123) shliou@nhri.org.tw
  Tsui-Chun Tsou (1)
  Shu-Li Wang (13)
  Lih-Ann Li (1)
  Hung-Che Chiang (1)
  Wan-Fen Li (1)
  Pin-Pin Lin (1)
  Ching-Huang Lai (2)
  Hui-Ling Lee (4)
  Ming-Hsiu Lin (5)
  Jin-Huei Hsu (5)
  Chiou-Rong Chen (5)
  Tung-Sheng Shih (35)
  Hui-Yi Liao (1)
  Yu-Teh Chung (1)
• 关键词：Nanoparticle – ; Lung inflammation – ; Antioxidant enzymes – ; Oxidative stress – ; Cardiovascular diseases – ; Genotoxicity – ; Pulmonary function – ; Control banding – ; Risk levels – ; Cross ; sectional study – ; Environmental and health effects
• 刊名：Journal of Nanoparticle Research
• 出版年：2012
• 出版时间：August 2012
• 年：2012
• 卷：14
• 期：8
• 全文大小：286.8 KB
• 参考文献：1. ACOEM Nanoparticle Task Force (2011) Nanotechnology and health. J Occup Environ Med 53:687–689
  2. American Thoracic Society Workshop (2006) ATS Workshop Proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate: executive summary. Am J Respir Crit Care Med 173:811–813
  3. Araujo JA, Nel AE (2009) Particulate matter and atherosclerosis: role of particle size, composition and oxidative stress. Part Fibre Toxicol 6:24–42
  4. Araujo JA, Barajas B, Kleinman M, Wang X, Bennett BJ, Gong KW, Navab M, Harkema J, Sioutas C, Lusis AJ, Nel AE (2008) Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ Res 102:589–596
  5. Becker H, Herzberg F, Schulte A, Kolossa-Gehring M (2011) The carcinogenic potential of nanomaterials, their release from products and options for regulating them. Int J Hyg Environ Health 214:231–238
  6. Bonner JC (2010) Nanoparticles as a potential cause of pleural and interstitial lung disease. Proc Am Thorac Soc 7:138–141
  7. Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J, Krutmann J, Warheit D, Oberd枚rster E (2006) The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 3:11–45
  8. Cassidy A, ‘t Mannetje A, van Tongeren M, Field JK, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, Lissowska J, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Fevotte J, Fletcher T, Brennan P, Boffetta P (2007) Occupational exposure to crystalline silica and risk of lung cancer: a multicenter case–control study in Europe. Epidemiology 18:36–43
  9. Chen HI, Liou SH, Ho SF, Wu KY, Sun CW, Chen MF, Cheng LC, Shih TS, Loh CH (2007a) Oxidative DNA damage estimated by plasma 8-hydroxydeoxyguanosine (8-OHdG): influence of 4,4′-methylenebis (2-chloroaniline) exposure and smoking. J Occup Health 49:389–398
  10. Chen W, Bochmann F, Sun Y (2007b) Effects of work related confounders on the association between silica exposure and lung cancer: a nested case-control study among Chinese miners and pottery workers. Int Arch Occup Environ Health 80:320–326
  11. Delfino RJ, Staimer N, Tjoa T, Polidori A, Arhami M, Gillen DL, Kleinman MT, Vaziri ND, Longhurst J, Zaldivar F, Sioutas C (2008) Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspect 116:898–906
  12. Dell LD, Mundt KA, Luippold RS, Nunes AP, Cohen L, Burch MT, Heidenreich MJ, Bachand AM, International Carbon Black Association (2006) A cohort mortality study of employees in the U.S. carbon black industry. J Occup Environ Med 48:1219–1229
  13. Donaldson K, Stone V, Seaton A, MacNee W (2001) Ambient particle inhalation and the cardiovascular system: potential mechanisms. Environ Health Perspect 109(Suppl 4):523–527
  14. Frampton MW (2007) Does inhalation of ultrafine particles cause pulmonary vascular effects in humans? Inhal Toxicol 19(Suppl 1):75–79
  15. Han SG, Castranova V, Vallyathan V (2005) Heat shock protein 70 as an indicator of early lung injury caused by exposure to arsenic. Mol Cell Biochem 277:153–164
  16. Hesterberg TW, Bunn WB 3rd, Chase GR, Valberg PA, Slavin TJ, Lapin CA, Hart GA (2006) A critical assessment of studies on the carcinogenic potential of diesel exhaust. Crit Rev Toxicol 36:727–776
  17. Hesterberg TW, Long CM, Bunn WB, Sax SN, Lapin CA, Valberg PA (2009) Non-cancer health effects of diesel exhaust: a critical assessment of recent human and animal toxicological literature. Crit Rev Toxicol 39:195–227
  18. Hesterberg TW, Long CM, Lapin CA, Hamade AK, Valberg PA (2010) Diesel exhaust particulate (DEP) and nanoparticle exposures: what do DEP human clinical studies tell us about potential human health hazards of nanoparticles? Inhal Toxicol 22:679–694
  19. Hoffmeyer F, Raulf-Heimsoth M, Merget R, Br眉ning T (2009) EBC: a new matrix for assessment of airway and lung inflammation. Current aspects of environmental and occupational medicine. Pneumologie 63:426–432
  20. Horv谩th I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, Becher G, van Beurden WJ, Corradi M, Dekhuijzen R, Dweik RA, Dwyer T, Effros R, Erzurum S, Gaston B, Gessner C, Greening A, Ho LP, Hohlfeld J, J枚bsis Q, Laskowski D, Loukides S, Marlin D, Montuschi P, Olin AC, Redington AE, Reinhold P, van Rensen EL, Rubinstein I, Silkoff P, Toren K, Vass G, Vogelberg C, Wirtz H, ATS/ERS Task Force on Exhaled Breath Condensate (2005) Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26:523–548
  21. Hubbs AF, Mercer RR, Benkovic SA, Harkema J, Sriram K, Schwegler-Berry D, Goravanahally MP, Nurkiewicz TR, Castranova V, Sargent LM (2011) Nanotoxicology—a pathologist’s perspective. Toxicol Pathol 39:301–324
  22. Karlsson HL (2010) The comet assay in nanotoxicology research. Anal Bioanal Chem 398:651–666
  23. Larsson K, Eklund A, Arns R, L枚wgren H, Nystr枚m J, Sundstr枚m G, Tornling G (1989) Lung function and bronchial reactivity in aluminum potroom workers. Scand J Work Environ Health 15:296–301
  24. Li WF, Sun CW, Cheng TJ, Chang KH, Chen CJ, Wang SL (2009) Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan. Toxicol Appl Pharmacol 236:246–253
  25. Liang Y, Wei P, Duke RW, Reaven PD, Harman SM, Cutler RG, Heward CB (2003) Quantification of 8-iso-prostaglandin-F2α and 2,3-dinor-8-iso-prostaglandin-F2α in human urine using liquid chromatography-tandem mass spectrometry. Free Radical Biol Med 34:409–418
  26. McAuley DF, Matthay MA (2009) Clara cell protein CC16. A new lung epithelial biomarker for acute lung injury. Chest 135:1408–1410
  27. Morfeld P, B眉chte SF, Wellmann J, McCunney RJ, Piekarski C (2006) Lung cancer mortality and carbon black exposure: Cox regression analysis of a cohort from a German carbon black production plant. J Occup Environ Med 48:1230–1241
  28. Nasterlack M (2011) Role of medical surveillance in risk management. J Occup Environ Med 53:S18–S21
  29. Nasterlack M, Zober A, Oberlinner C (2008) Considerations on occupational medical surveillance in employees handling nanoparticles. Int Arch Occup Environ Health 81:721–726
  30. Oberd枚rster G (2010) Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 267:89–105
  31. Oberd枚rster G, Oberd枚rster E, Oberd枚rster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839
  32. Oberd枚rster G, Elder A, Rinderknecht A (2009) Nanoparticles and the brain: cause for concern? J Nanosci Nanotechnol 9:4996–5007
  33. Ostiguy C, Soucy B, Lapointe G, Woods C, M茅nard L, Trottie M (2008) Health effects of nanoparticles, 2nd edn. Chemical Substances and Biological Agents, Studies and Research Projects, R-589, The Institut de recherche Robert-Sauv茅 en sant茅 et en s茅curit茅 du travail (IRSST), Canada
  34. Paik SY, Zalk DM, Swuste P (2008) Application of a pilot control banding tool for risk level assessment and control of nanoparticle exposures. Ann Occup Hyg 52:419–428
  35. Pauluhn J, Hahn A, Spielmann H (2008) Assessment of early acute lung injury in rats exposed to aerosols of consumer products: attempt to disentangle the “Magic Nano” conundrum. Inhal Toxicol 20:1245–1262
  36. Peters A, Breitner S, Cyrys J, St枚lzel M, Pitz M, W枚lke G, Heinrich J, Kreyling W, K眉chenhoff H, Wichmann HE (2009) The influence of improved air quality on mortality risks in Erfurt, Germany. Res Rep Health Eff Inst 137:5–77 discussion 79-90
  37. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Sch眉nemann H, Wedzicha W, MacDonald R, Shekelle P; American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society (2011) Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 155:179–191
  38. Quan C, Sun Q, Lippmann M, Chen LC (2010) Comparative effects of inhaled diesel exhaust and ambient fine particles on inflammation, atherosclerosis, and vascular dysfunction. Inhal Toxicol 22:738–753
  39. Radon K, Nowak D, Szadkowski D (1999) Lack of combined effects of exposure and smoking on respiratory health in aluminium potroom workers. Occup Environ Med 56:468–472
  40. Ramanakumar AV, Parent ME, Latreille B, Siemiatycki J (2008) Risk of lung cancer following exposure to carbon black, titanium dioxide and talc: results from two case-control studies in Montreal. Int J Cancer 122:183–189
  41. Ridker PM (2007) C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 49:2129–2138
  42. Schulte PA, Trout D, Zumwalde RD, Kuempel E, Geraci CL, Castranova V, Mundt DJ, Mundt KA, Halperin WE (2008) Options for occupational health surveillance of workers potentially exposed to engineered nanoparticles: state of the science. J Occup Environ Med 50:517–526
  43. Simk贸 M, Mattsson MO (2010) Risks from accidental exposures to engineered nanoparticles and neurological health effects: a critical review. Part Fibre Toxicol 7:42–56
  44. Song Y, Li X, Du X (2009) Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur Respir J 34:559–567
  45. Stern ST, McNeil SE (2008) Nanotechnology safety concerns revisited. Toxicol Sci 101:4–21
  46. Stone V, Johnston H, Clift MJ (2007) Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions. IEEE Trans Nanobioscience 6:331–340
  47. Taylor DR, Pijnenburg MW, Smith AD, De Jongste JC (2006) Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 61:817–827
  48. Terzano C, Di Stefano F, Conti V, Graziani E, Petroianni A (2010) Air pollution ultrafine particles: toxicity beyond the lung. Eur Rev Med Pharmacol Sci 14:809–821
  49. Theegarten D, Boukercha S, Philippou S, Anhenn O (2010) Submesothelial deposition of carbon nanoparticles after toner exposition: case report. Diagn Pathol 5:77–81
  50. Timonen KL, Vanninen E, de Hartog J, Ibald-Mulli A, Brunekreef B, Gold DR, Heinrich J, Hoek G, Lanki T, Peters A, Tarkiainen T, Tiittanen P, Kreyling W, Pekkanen J (2006) Effects of ultrafine and fine particulate and gaseous air pollution on cardiac autonomic control in subjects with coronary artery disease: the ULTRA study. J Expo Sci Environ Epidemiol 16:332–341
  51. Tsai SY, Chen JD, Chao WY, Wang JD (1997) Neurobehavioral effects of occupational exposure to low-level organic solvents among Taiwanese workers in paint factories. Environ Res 73:146–155
  52. Tsou TC, Yeh SC, Tsai FY, Lin HJ, Cheng TJ, Chao HR, Tai LA (2010) Zinc oxide particles induce inflammatory responses in vascular endothelial cells via NF-κB signaling. J Hazard Mater 183:182–188
  53. Wang CJ, Yang NH, Chang CC, Liou SH, Lee HL (2011) Rapid and simple one-step membrane extraction for the determination of 8-hydroxy-2′-deoxyguanosine in human plasma by a combination of on-line solid phase extraction and LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 879:3538–3543
  54. Wichmann HE, Spix C, Tuch T, W枚lke G, Peters A, Heinrich J, Kreyling WG, Heyder J (2000) Daily mortality and fine and ultrafine particles in Erfurt, Germany part I: role of particle number and particle mass. Res Rep Health Eff Inst 98:5–86 discussion 87-94
  55. Wolinsky H (2006) A recent scare involving nanotech products reveals that the technology is not yet properly regulated. EMBO Rep 7:858–861
  56. Wu PA, Loh CH, Hsieh LL, Liu TY, Chen CJ, Liou SH (2004) Clastogenic effect for cigarette smoking but not areca quid chewing as measured by micronuclei in exfoliated buccal mucosal cells. Mutat Res 562:27–38
  57. Zelko I, Mariani T, Folz R (2002) Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33:337–349
• 作者单位：1. Division of Environmental Health & Occupational Medicine, National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County, 35053 Taiwan, ROC2. Department of Public Health, National Defense Medical Center, Taipei, Taiwan, ROC3. Institute of Environmental Health, College of Public Health, China Medical University and Hospital, Taichung, Taiwan, ROC4. Department of Chemistry, Fu Jen Catholic University, Taipei, Taiwan, ROC5. Institute of Occupational Safety and Health, Council of Labor Affairs, Taipei, Taiwan, ROC
• ISSN：1572-896X

文摘

The aim of this study was to establish and identify the health effect markers of workers with potential exposure to nanoparticles (20–100 nm) during manufacturing and/or application of nanomaterials. For this cross-sectional study, we recruited 227 workers who handled nanomaterials and 137 workers for comparison who did not from 14 plants in Taiwan. A questionnaire was used to collect data on exposure status, demographics, and potential confounders. The health effect markers were measured in the medical laboratory. Control banding from the Nanotool Risk Level Matrix was used to categorize the exposure risk levels of the workers. The results showed that the antioxidant enzyme, superoxide dismutase (SOD) in risk level 1 (RL1) and risk level 2 (RL2) workers was significantly (p < 0.05) lower than in control workers. A significantly decreasing gradient was found for SOD (control > RL1 > RL2). Another antioxidant, glutathione peroxidase (GPX), was significantly lower only in RL1 workers than in the control workers. The cardiovascular markers, fibrinogen and ICAM (intercellular adhesion molecule), were significantly higher in RL2 workers than in controls and a significant dose–response with an increasing trend was found for these two cardiovascular markers. Another cardiovascular marker, interleukin-6, was significantly increased among RL1 workers, but not among RL2 workers. The accuracy rate for remembering 7-digits and reciting them backwards was significantly lower in RL2 workers (OR = 0.48) than in controls and a significantly reversed gradient was also found for the correct rate of backward memory (OR = 0.90 for RL1, OR = 0.48 for RL2, p < 0.05 in test for trend). Depression of antioxidant enzymes and increased expression of cardiovascular markers were found among workers handling nanomaterials. Antioxidant enzymes, such as SOD and GPX, and cardiovascular markers, such as fibrinogen, ICAM, and interluekin-6, are possible biomarkers for medical surveillance of workers handling engineered nanomaterials.